GlassScriptPhysician profile
Troy A Bunting
NPI 1558588962
$16,013.34
in general payments reported to CMS, 2019-2025
51 companies · $3,867 in 2025
The $3,867 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,726 · 2020: $2,639 · 2021: $717 · 2022: $979 · 2023: $1,480 · 2024: $3,605 · 2025: $3,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,293 · Travel and Lodging: $1,588 · Entertainment: $71.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,292.90 |
| Travel and Lodging | $1,587.76 |
| Entertainment | $71.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,415.71 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,352.27 | 2019-2025 | Amplatzer Amulet, Jot Dx, Gallant |
| Medtronic, INC. | $1,677.15 | 2021-2025 | Symplicity G3, Onyx Frontier, Aurora Ev-Icd Mri Surescan |
| Amgen INC. | $812.66 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $698.32 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Boston Scientific Corporation | $647.08 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $479.37 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $452.74 | 2019-2025 | Lifevest |
| Philips North America LLC | $385.26 | 2022-2025 | (Ck4) Mcot, Ecc Solutions, Ambulatory Monitoring & Diagnostics Undivided |
| E.R. Squibb & Sons, L.L.C. | $370.32 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $357.39 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $342.86 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $285.64 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $255.97 | 2019-2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $255.12 | 2019-2025 | Onpattro, Amvuttra |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $247.96 | 2024-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $244.22 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $229.11 | 2025 | Cios Flow |
| Medtronic Vascular, INC. | $212.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $205.65 | 2019-2022 | |
| Novo Nordisk INC | $187.47 | 2024-2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $182.69 | 2019-2024 | Praluent, Evkeeza |
| Cms Imaging, INC. | $178.68 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $172.99 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $169.82 | 2021-2023 | Verquvo |
| Cardiovascular Systems INC. | $147.40 | 2022-2023 | Diamondback Coronary |
| Esperion Therapeutics, INC. | $129.91 | 2022-2025 | Nexletol |
| Cardiva Medical, INC. | $124.78 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Astellas Pharma US INC | $89.36 | 2019-2020 | |
| Amarin Pharma, INC. | $74.44 | 2019-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $68.44 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $61.04 | 2025 | |
| Shockwave Medical, INC | $56.44 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardinal Health 200 LLC | $50.65 | 2019-2020 | |
| Ge Healthcare | $46.27 | 2020 | |
| Akcea Therapeutics, INC. | $41.57 | 2021 | |
| Cvrx, INC. | $33.33 | 2022-2024 | Barostim Neo System |
| Heartflow, INC. | $29.27 | 2019 | |
| Bardy Diagnostics, INC. | $27.00 | 2019 | |
| Bridgebio Pharma, INC. | $25.65 | 2025 | Attruby |
| Stryker Corporation | $22.05 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $21.66 | 2020 | |
| Scpharmaceuticals INC. | $18.76 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $18.36 | 2023 | Inpefa |
| Lundbeck LLC | $17.91 | 2019 | |
| Preventice Services, LLC | $17.09 | 2019 | |
| Glaxosmithkline, LLC. | $15.60 | 2025 | Arexvy, Shingrix |
| Teleflex LLC | $15.36 | 2022 | |
| Innovation Technologies INC | $15.20 | 2025 | Irrisept |
| Atricure, INC. | $14.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Bunting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.